Alamar Biosciences, Inc.
ALMR
$29.16
-$0.79-2.64%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | 38.11% | 8.30% | |||
| Total Depreciation and Amortization | -2.83% | 3.49% | |||
| Total Amortization of Deferred Charges | 4.48% | 4.76% | |||
| Total Other Non-Cash Items | -51.02% | -0.83% | |||
| Change in Net Operating Assets | 58.03% | 7.41% | |||
| Cash from Operations | 44.36% | 9.08% | |||
| Capital Expenditure | -507.00% | -35.92% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -65,716.85% | 6.41% | |||
| Cash from Investing | -15,426.48% | 5.45% | |||
| Total Debt Issued | -100.00% | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 11,312.81% | -32.51% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 187.25% | -- | |||
| Cash from Financing | 261.98% | -32.51% | |||
| Foreign Exchange rate Adjustments | 113.46% | 152.63% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 101.63% | 51.71% | |||